Latest Conference Articles

Sustainable health care models require buy-in from multiple stakeholders, including pharmacists, payers, and patients.

Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.

As clinical research continues, investigators are learning more about how GLP-1 drugs modify cardiovascular risks.

Lifestyle changes—including eating fruits, vegetables, and whole grains—can help patients, especially those with diabetes or hypertension, improve outcomes.

Sharing concrete steps and suggestions can help ease the way for patients looking to transition to a more healthful lifestyle.

Health care professionals all agree that a healthy diet is the foundation of cardiovascular and cardiometabolic health, but follow-through on the population level is lacking.

GLP-1 therapies are being evaluated to treat cardiovascular and kidney diseases in individuals with overweight or obesity.

These therapies are highly beneficial, but can come with a host of gastrointestinal adverse effects that patients may not be prepared to manage alone.

Some patients may have difficulty managing the gastrointestinal adverse effects associated with GLP-1 therapies.

Look back at some of the amazing insights during McKesson ideaShare, the premier event for community pharmacists.

Chris Cella, RPh, vice president of RxOwnership at McKesson, talks about how independent pharmacies can help improve their bottom line.

McKesson’s private brand of OTC health and wellness products are a great way for independent pharmacies to increase profits.

Emily Flaugher, Vice President and General Manager of Health Mart Atlas and Atlas Specialty at McKesson, sat down with Drug Topics to discuss McKesson solutions that help independent pharmacists maximize reimbursement.

Three posters presented at the American Diabetes Association 84th Scientific Sessions examined GLP-1 use and cardiovascular disease risk in several different patient populations.

Three posters presented at the American Diabetes Association 84th Scientific Sessions looked into the current landscape of GLP-1s.

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

Two posters presented at the American Diabetes Association 84th Scientific Sessions looked into the impact of glucagon-like peptide-1 receptor agonists in type 1 diabetes management.

Drug Topics has been on site at McKesson ideaShare this week! Check out this podcast to hear a few of the things we've experienced and what we've learned so far.

Two posters presented at the American Diabetes Association 84th Scientific Sessions looked at challenges of remote CGM in older populations and after discharge from the hospital.

During a session at McKesson ideaShare 2024, Martin Dennis of RxOwnership was joined by digital marketing experts to discuss key marketing tools for independent pharmacies.

A selection of studies presented at the American Diabetes Association 84th Scientific Sessions examined the use of CGM technology in type 2 diabetes.

Access to diabetes self-management education and support services are crucial for improving diabetes outcomes.

Check out some of the latest research into diabetes medication options.

Drug Topics has been on site at McKesson ideaShare this week. Check out this podcast to hear a few of the exciting happenings at this year’s meeting.

Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.

A poster presented at AHS 2024 found that older patients tended to have more vitamin deficiencies compared to younger patients.

A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.

A posted presented at ASHP 2024 examined if improved access to methadone could decrease hospital length of stay and readmission rates.